-transparent.png){kind=logo}
Thirty two patients with malignant lymphoma - mainly Hodgkin's disease - were randomized for simultaneous treatment by high doses of metenolone during MOPP chemotherapy, to reduce its hematological toxicity. The results have shown surprisingly an increased hemato-toxicity in patients receiving androgens, with significantly more marked anemia and thrombocytopenia, reducing the total doses of anti-cancer drugs. This side effect could be explained by a cycling of the hematopoietic stem-cells and call to some caution when androgens are used during cancer chemotherapy.
Related Publications
R Zittoun, and
M Barthélémy, and
M Bouchard, and
C M Blanc, and
J Bousser, and
G Bilski-Pasquier
January 1982,
[Rinsho ketsueki] The Japanese journal of clinical hematology,
R Zittoun, and
M Barthélémy, and
M Bouchard, and
C M Blanc, and
J Bousser, and
G Bilski-Pasquier
January 1982,
Nouvelle revue francaise d'hematologie,
R Zittoun, and
M Barthélémy, and
M Bouchard, and
C M Blanc, and
J Bousser, and
G Bilski-Pasquier
January 1982,
Archiv fur Geschwulstforschung,
R Zittoun, and
M Barthélémy, and
M Bouchard, and
C M Blanc, and
J Bousser, and
G Bilski-Pasquier
December 1978,
Cancer treatment reports,
R Zittoun, and
M Barthélémy, and
M Bouchard, and
C M Blanc, and
J Bousser, and
G Bilski-Pasquier
November 1991,
Harefuah,
R Zittoun, and
M Barthélémy, and
M Bouchard, and
C M Blanc, and
J Bousser, and
G Bilski-Pasquier
September 1981,
JAMA,
R Zittoun, and
M Barthélémy, and
M Bouchard, and
C M Blanc, and
J Bousser, and
G Bilski-Pasquier
April 1990,
Gan to kagaku ryoho. Cancer & chemotherapy,
R Zittoun, and
M Barthélémy, and
M Bouchard, and
C M Blanc, and
J Bousser, and
G Bilski-Pasquier
January 1974,
Annales d'endocrinologie,
R Zittoun, and
M Barthélémy, and
M Bouchard, and
C M Blanc, and
J Bousser, and
G Bilski-Pasquier
February 1981,
Yao xue xue bao = Acta pharmaceutica Sinica,
R Zittoun, and
M Barthélémy, and
M Bouchard, and
C M Blanc, and
J Bousser, and
G Bilski-Pasquier
January 1979,
Bulletin du cancer,
